Skip to content
Screener

Arcturus Therapeutics ARCT Q4 2025 Annual earnings

Reported March 3, 2026 · After market close

Revenue$7.2MMiss by $8.7M
EPS-$1.03Miss by $0.11
Revenue estimate$15.9M
EPS estimate-$0.92

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$8.0M
EPS estimate-$0.67

FAQ

When did Arcturus Therapeutics report Q4 2025 earnings?
Arcturus Therapeutics (ARCT) reported Q4 2025 earnings on March 3, 2026 after market close.
What were Arcturus Therapeutics's Q4 2025 revenue and EPS?
Arcturus Therapeutics reported revenue of $7.2M and eps of $-1.03 for Q4 2025.
Did Arcturus Therapeutics beat estimates in Q4 2025?
Revenue missed the consensus estimate of $15.9M by $8.7M. EPS missed the consensus estimate of $-0.92 by $0.11.
How did Arcturus Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 65.7% from $21.0M a year earlier and eps grew 7.2% from $-1.11.
Where can I find Arcturus Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193805-26-000214) and the 10-K periodic report (0001193125-26-088391) directly on SEC EDGAR. The filing index links above go to sec.gov.